Socrates E. Papapoulos - Publications

Alendronate for 6 or 12 months following denosumab discontinuation in women with postmenopausal osteoporosis: A prospective observational study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: February 10, 2026

Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosis.

Journal: Bone reports

Published: November 05, 2025

Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS).

Journal: Bone

Published: October 19, 2025

Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the Future.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 12, 2025

Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trials.

Journal: BMJ oncology

Published: May 10, 2025

No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: March 27, 2025

Atypical fractures at non-classical sites associated with anti-resorptive therapy: a systematic review.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: January 18, 2025

Long-term clinical and bone mineral density changes of adult patients with sclerostin deficiency due to van Buchem disease: a follow-up study.

Journal: JBMR plus

Published: October 03, 2024

Cyclical Etidronate Reduces the Progression of Arterial Calcifications in Patients with Pseudoxanthoma Elasticum: A 6-Year Prospective Observational Study.

Journal: Journal of clinical medicine

Published: June 02, 2024

Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: October 29, 2023

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab.

Journal: Journal of clinical medicine

Published: July 21, 2023

The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis.

Journal: Calcified tissue international

Published: May 14, 2023